MAYORANDIL 5: Dual-Action Relief for Stable Angina

 MAYORANDIL 5, manufactured by Steris Healthcare, is an anti-anginal medication formulated with Nicorandil 5mg. This medication belongs to a unique class of vasodilators known as potassium channel activators, and it is prescribed for the prevention and long-term management of stable angina pectoris — the chest pain or discomfort that occurs when the heart muscle does not receive enough oxygen-rich blood. By relaxing and widening both coronary arteries and blood vessels throughout the body, MAYORANDIL 5 helps improve blood flow to the heart, reducing the frequency and severity of angina episodes.

Why It's Important

Angina is a warning sign that the heart is not receiving adequate oxygen supply, typically due to narrowed or partially blocked coronary arteries. Left inadequately managed, recurrent angina can significantly limit a person's ability to carry out everyday physical activities and may increase the risk of more serious cardiac events over time. What makes MAYORANDIL 5 clinically distinctive is its dual mechanism of action — unlike conventional nitrates or calcium channel blockers that work through a single pathway, Nicorandil combines nitrate-like venodilation with potassium channel activation, giving it both an immediate symptom-relieving effect and a protective, cardioprotective quality linked to ischemic preconditioning. This dual action makes it a valuable option for patients who need effective angina control, particularly those who have not achieved adequate relief with other anti-anginal agents alone, helping them maintain better exercise tolerance and overall cardiac stability.

Key Benefits 

What Are the Benefits of This Combination?

• Effectively reduces the frequency and severity of stable angina episodes
• Dual mechanism of action provides both symptomatic relief and cardioprotective benefits
• Improves coronary blood flow by relaxing coronary artery smooth muscle
• Helps improve exercise tolerance in patients with chronic stable angina
• May offer additional benefit through ischemic preconditioning-like cardioprotective effects
• Can be used alongside other anti-anginal therapies when angina is not adequately controlled with a single agent
• Available in a convenient oral tablet form suitable for long-term maintenance therapy

Side Effects

MAYORANDIL 5 is generally well-tolerated, but like all cardiovascular medications, it may cause side effects in some patients, particularly when treatment is first initiated. Commonly reported effects include headache (especially during the first few days of treatment), dizziness, flushing, nausea, and mild palpitations. These effects are often dose-related and tend to improve as the body adjusts to the medication.

Serious Side Effects

Though less common, patients should seek immediate medical attention if they experience signs of a severe allergic reaction (swelling of the face or throat, skin rash, difficulty breathing), significant drop in blood pressure (severe dizziness, fainting), signs of gastrointestinal, anal, or skin ulceration (unusual pain, bleeding, or non-healing sores — a recognized but uncommon effect associated with long-term Nicorandil use), or worsening chest pain despite treatment. Any of these symptoms should be evaluated by a physician without delay.

Available Substitutes

Several Nicorandil formulations are available in the Indian pharmaceutical market, differing in strength (commonly 5mg and 10mg) and brand. Patients should not switch between different Nicorandil brands or strengths without consulting their physician, as dosage adjustments should be made gradually and under medical supervision to avoid inadequate angina control or excessive blood pressure lowering. For a Steris Healthcare-manufactured alternative or a different strength, patients and PCD franchise partners are encouraged to consult the company's product portfolio directly.

Dosage Guidelines 

Dosage must always be individualized by a physician based on the severity of angina, patient tolerance, and response to initial therapy. MAYORANDIL 5 is typically started at a low dose and taken twice daily, with the dose adjusted gradually based on clinical response and tolerability. It can be taken with or without food, and tablets should be swallowed with a glass of water. Patients should not stop this medication abruptly, as doing so may lead to a rebound worsening of angina symptoms; any change in dosage or discontinuation should always be guided by a physician.

Precautions & Warnings

MAYORANDIL 5 should not be used in patients with cardiogenic shock, severe hypotension, or acute left ventricular failure with low filling pressure. It should be used with caution in patients with a history of ulcerative conditions, as Nicorandil has been associated with gastrointestinal and mucosal ulceration in some cases, particularly with prolonged use. Concurrent use with PDE5 inhibitors (medications for erectile dysfunction) is contraindicated, as this combination can cause a severe, potentially dangerous drop in blood pressure. Caution is advised in patients with low blood volume, hypovolemia, or those taking other blood pressure-lowering medications, due to the additive hypotensive effect. This medication should be used cautiously in pregnant or breastfeeding women, only under medical supervision. Patients should inform their physician of all other medications, particularly nitrates or vasodilators, to avoid excessive additive effects.

How to Use & Mechanism of Action

MAYORANDIL 5 should be taken orally, generally twice daily as prescribed, with tablets swallowed whole with water and taken at consistent times to maintain steady drug levels. Its effectiveness comes from Nicorandil's distinctive dual mechanism of action. As a potassium channel activator, it opens ATP-sensitive potassium channels in vascular smooth muscle, leading to hyperpolarization of the cell membrane and relaxation of arterial smooth muscle, including the coronary arteries — this widens blood vessels and improves oxygen-rich blood flow to the heart muscle. At the same time, Nicorandil possesses a nitrate-like component that promotes venodilation, reducing the workload on the heart by decreasing the volume of blood returning to it (preload). This combined arterial and venous dilating effect, along with a potential cardioprotective action resembling ischemic preconditioning, gives Nicorandil its distinctive ability to both relieve angina symptoms and support overall cardiac resilience.

Conclusion

MAYORANDIL 5 by Steris Healthcare offers a clinically distinctive approach to managing stable angina through the dual-action mechanism of Nicorandil Tablets 5mg. By combining potassium channel activation with nitrate-like vasodilation, it provides both immediate symptomatic relief and a potential cardioprotective benefit that sets it apart from conventional anti-anginal agents. As with any cardiovascular medication, treatment should be initiated gradually and monitored closely by a physician, with attention to potential drug interactions and rare but recognized risks such as mucosal ulceration during long-term use.